帕金森病清醒与睡眠状态下深部脑刺激的临床结局
本研究在单中心前瞻性监测接受双侧GPi或STN DBS的帕金森病患者,比较清醒与睡眠(全麻无微电极记录)技术。6个月随访显示,两种技术在运动功能改善、生活质量及左旋多巴等效日剂量变化上均无显著差异。
要点
- GPi靶点UPDRS-III改善:清醒组20.8分(38.5%)vs 睡眠组18.8分(37.5%),p=0.45。
- STN靶点UPDRS-III改善:清醒组21.6分(40.3%)vs 睡眠组26.1分(48.8%),p=0.20。
- PDQ-39与LEDD变化在GPi和STN队列中清醒与睡眠组均相似。
核心结论
- 帕金森病患者采用睡眠法行双侧GPi和STN DBS,其运动、生活质量及药物减量结局与清醒法相当。
研究设计与样本
- 单中心前瞻性监测接受清醒或睡眠双侧GPi或STN DBS的帕金森病患者。
- 45个月内共133例患者有6个月结局数据:GPi 78例(清醒16例,睡眠62例),STN 55例(清醒14例,睡眠41例)。
主要发现
- GPi靶点UPDRS-III刺激诱导改善:清醒组20.8分(38.5%)vs 睡眠组18.8分(37.5%),p=0.45。
- STN靶点UPDRS-III刺激诱导改善:清醒组21.6分(40.3%)vs 睡眠组26.1分(48.8%),p=0.20。
- PDQ-39改善百分比在GPi队列清醒与睡眠组间p=0.80,STN队列p=0.85。
- LEDD改善百分比在GPi队列清醒与睡眠组间p=0.54,STN队列p=0.49。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Recent studies have shown similar clinical outcomes between Parkinson disease (PD) patients treated with deep brain stimulation (DBS) under general anesthesia without microelectrode recording (MER), so-called “asleep” DBS, and historical cohorts undergoing “awake” DBS with MER guidance. However, few studies include internal controls. This study aims to compare clinical outcomes after globus pallidus internus (GPi) and subthalamic nucleus (STN) DBS using awake and asleep techniques at a single institution. METHODS: PD patients undergoing awake or asleep bilateral GPi or STN DBS were prospectively monitored. The primary outcome measure was stimulation-induced change in motor function off medication 6 months postoperatively, measured using the Unified Parkinson’s Disease Rating Scale part III (UPDRS-III). Secondary outcomes included change in quality of life, measured by the 39-item Parkinson’s Disease Questionnaire (PDQ-39), change in levodopa equivalent daily dosage (LEDD), stereotactic accuracy, stimulation parameters, and adverse events. RESULTS: Six-month outcome data were available for 133 patients treated over 45 months (78 GPi [16 awake, 62 asleep] and 55 STN [14 awake, 41 asleep]). UPDRS-III score improvement with stimulation did not differ between awake and asleep groups for GPi (awake, 20.8 points [38.5%]; asleep, 18.8 points [37.5%]; p = 0.45) or STN (awake, 21.6 points [40.3%]; asleep, 26.1 points [48.8%]; p = 0.20) targets. The percentage improvement in PDQ-39 and LEDD was similar for awake and asleep groups for both GPi (p = 0.80 and p = 0.54, respectively) and STN cohorts (p = 0.85 and p = 0.49, respectively). CONCLUSIONS: In PD patients, bilateral GPi and STN DBS using the asleep method resulted in motor, quality-of-life, and medication reduction outcomes that were comparable to those of the awake method.
引用
- Chen T, Mirzadeh Z, Chapple KM, et al. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease. J Neurosurg. 2018. PMID: 29547091. doi:10.3171/2017.8.JNS17883
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。